- Filed
- May 10, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $9.18M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $2.85M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $6.96M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $5.61M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $8.41M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $6.6M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $10.41M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $4.1M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $21.56M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $13.26M |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 124.84K sh |
| Capex | Q1 2024 · Mar 31, 2023 | $94K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$9.37M |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | $7.93M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | −$9.05M |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | −$97.48 |
| Eps Basic restated | Q1 2024 · Mar 31, 2023 | −$97.48 |
| Sga Expense restated | Q1 2024 · Mar 31, 2023 | $9.49M |
| Rd Expense restated | Q1 2024 · Mar 31, 2023 | $3.96M |
| Net Income restated | Q1 2024 · Mar 31, 2023 | −$12.17M |
| Operating Income restated | Q1 2024 · Mar 31, 2023 | −$13.48M |